banner

News Releases

None | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
Date Title
12/20/16
ACADIA Pharmaceuticals Announces Positive Top-Line Results From Phase II Study of Pimavanserin for Alzheimer’s Disease Psychosis
12/01/16
ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Major Depressive Disorder
11/15/16
ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia
11/07/16
ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results
11/03/16
ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia
11/01/16
ACADIA Pharmaceuticals to Announce Third Quarter 2016 Financial Results on November 7, 2016
10/31/16
ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation
10/11/16
ACADIA Pharmaceuticals Receives California Life Sciences Association’s 2016 Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID™
09/20/16
ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016
09/19/16
ACADIA Pharmaceuticals Sponsors National Parkinson Foundation’s Caregiver Summit
09/06/16
ACADIA Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2016
08/24/16
ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer
08/23/16
ACADIA Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
08/09/16
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
08/08/16
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
08/04/16
ACADIA Pharmaceuticals Reports Second Quarter 2016 Financial Results
07/29/16
ACADIA Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 4, 2016
06/27/16
ACADIA Pharmaceuticals Added to Large-Cap Russell 1000 Market Index
06/16/16
ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016
06/01/16
ACADIA Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on June 8, 2016
05/31/16
ACADIA Pharmaceuticals Announces NUPLAZID™ (pimavanserin) Is Now Available for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
05/05/16
ACADIA Pharmaceuticals Reports First Quarter 2016 Financial Results
05/04/16
ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016
05/02/16
ACADIA Pharmaceuticals to Announce First Quarter 2016 Financial Results on May 5, 2016
04/29/16
FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) - The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
04/06/16
ACADIA Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016
03/29/16
FDA Advisory Committee Votes 12 to 2 That Benefits of ACADIA Pharmaceuticals’ NUPLAZID™ (Pimavanserin) for the Treatment of Psychosis Associated with Parkinson’s Disease Outweigh the Risks
03/29/16
ACADIA Pharmaceuticals Stock Trading Halted Today
03/01/16
ACADIA Pharmaceuticals to Present at the Cowen and Company 36th Annual Health Care Conference on March 8, 2016
02/29/16
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
02/23/16
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016
02/03/16
ACADIA Pharmaceuticals to Present at the LEERINK Partners 5th Annual Global Healthcare Conference on February 10, 2016
01/29/16
ACADIA Pharmaceuticals Announces FDA Advisory Committee Meeting to Review NUPLAZID™ (Pimavanserin) for the Treatment of Parkinson’s Disease Psychosis
01/25/16
ACADIA Pharmaceuticals Appoints James (Randy) R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer
01/11/16
ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors
01/07/16
ACADIA Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on January 12, 2016
01/06/16
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
01/05/16
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock